Hormone receptor positivity may even indicate a less favorable prognosis for young women, with a higher risk of distant relapses [51], therefore a tumor model for BRCA1 loss of function together with hormone receptor positivity is relevant for evaluating new treatment strategies. Here, NR4A1 is linked to neoplasm.